As expected, the downregulation of these 12 genes or 10 genes (excluding TNFSF11 and VAT1L genes from the list in Figure 2g) was associated with the reduced survival of patients with BC compared with that of patients with an upregulation of these genes (Figure 2h). The gene discussed is VAT1L; the disease is breast cancer.